Skip to content

Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01942642
Enrollment
48
Registered
2013-09-16
Start date
2012-11-30
Completion date
2013-04-30
Last updated
2013-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian Gland Dysfunction

Keywords

cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography

Brief summary

Meibomian gland dysfunction (MGD) is a common and important disease has been investigated the pathophysiology, diagnosis, treatment modalities of MGD, however, the changes of MGD after the cataract surgery, the most popular surgery to ophthalmologist, had not been evaluated. The investigators evaluated parameters related with MGD including lid margin abnormalities, meibomian gland expressibility and meibography before and after surgery.

Interventions

None listed

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 88 Years
Healthy volunteers
No

Inclusion criteria

1\. Patients scheduled for cataract surgery

Exclusion criteria

1. other comorbid ocular diseases such as ocular allergies. 2. continuous use of topical ocular medications before surgery 3. histories of ocular surgery, or ocular injury 4. Already had severe obstructive MGD before surgery, abnormal findings on lid margin (\> 3 positive findings), reduced meibum expression (\> grade 2), and obstructed gland dropout (meibography score \> 3)

Design outcomes

Primary

MeasureTime frameDescription
Ocular parameterschange of Ocular parameters from 1 to 3 months after cataract surgeryOcular symptom score, lid margin abnormalities, superficial punctuate keratopathy, tear film break-up time, Shirmer's test, lower tear meniscus height (TMH), depth (TMD), and area (TMA), meibum expressibility, and meibography score

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026